About the Authors

Kenneth W. Foreman

Contributed equally to this work with: Kenneth W. Foreman, Mark Brown, Philip Tucker

kforeman@coferon.com

Current address: Coferon Inc., New York, New York, United States of America

Affiliation OSI Pharmaceuticals, Inc., Farmingdale, New York, United States of America

Mark Brown

Contributed equally to this work with: Kenneth W. Foreman, Mark Brown, Philip Tucker

Current address: Colorado State University, Fort Collins, Colorado, United States of America

Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America

Frances Park

Affiliation AltheaDx, Inc., San Diego, California, United States of America

Spencer Emtage

Affiliation Eli Lilly and Company, San Diego, California, United States of America

June Harriss

Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America

Chhaya Das

Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America

Li Zhu

Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America

Andy Crew

Affiliation OSI Pharmaceuticals, Inc., Farmingdale, New York, United States of America

Lee Arnold

Affiliation DiscoverElucidations, LLC. Mt. Sinai, New York, United States of America

Salam Shaaban

Affiliation Abbott Bioresearch Center, Worcester, Massachusetts, United States of America

Philip Tucker

Contributed equally to this work with: Kenneth W. Foreman, Mark Brown, Philip Tucker

Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America

Competing Interests

KF, AC, LA, and SS were employed by OSI Pharmaceuticals at the time of the contribution and are currently employed at Coferon, Inc.; employed at OSI Pharmaceuticals, a wholly owned subsidiary of Astellas Pharma; self-employed (DiscoverElucidations); and employed at Abbott, respectively. FP and SE were employed at SGX Pharmaceuticals at the time of the contribution and are currently employed at AltheaDx and Eli Lilly, respectively. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: KWF FP SE AC LA SS PT. Performed the experiments: KWF MB JH CD LZ. Analyzed the data: KWF SS PT. Wrote the paper: KWF MB SS PT.